Billon, E.; Gravis, G.; Guille, A.; Carbuccia, N.; Adelaide, J.; Garnier, S.; Finetti, P.; Denicolaï, E.; Sfumato, P.; Brunelle, S.;
et al. Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial. Cancers 2022, 14, 2275.
https://doi.org/10.3390/cancers14092275
AMA Style
Billon E, Gravis G, Guille A, Carbuccia N, Adelaide J, Garnier S, Finetti P, Denicolaï E, Sfumato P, Brunelle S,
et al. Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial. Cancers. 2022; 14(9):2275.
https://doi.org/10.3390/cancers14092275
Chicago/Turabian Style
Billon, Emilien, Gwenaelle Gravis, Arnaud Guille, Nadine Carbuccia, Jose Adelaide, Séverine Garnier, Pascal Finetti, Emilie Denicolaï, Patrick Sfumato, Serge Brunelle,
and et al. 2022. "Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial" Cancers 14, no. 9: 2275.
https://doi.org/10.3390/cancers14092275
APA Style
Billon, E., Gravis, G., Guille, A., Carbuccia, N., Adelaide, J., Garnier, S., Finetti, P., Denicolaï, E., Sfumato, P., Brunelle, S., Thomassin-Piana, J., Pignot, G., Walz, J., Chabannon, C., Pakradouni, J., Sabatier, R., Vicier, C., Popovici, C., Mamessier, E.,
... Bertucci, F.
(2022). Molecular Profiles of Advanced Urological Cancers in the PERMED-01 Precision Medicine Clinical Trial. Cancers, 14(9), 2275.
https://doi.org/10.3390/cancers14092275
